Goal
Establish a comprehensive eye-healthcare platform from early diagnosis to effective treatment, ensuring global holistic care solutions.
Meet our Flagship Products
Unlock Our
Expertise
and Services
Reference
1. Conus V., Geiser M. A Review of Silent Substitution Devices for Melanopsin Stimulation in Humans. Photonics. 2020; 7(4):121
Reference
2. Evéquoz, G. et al. Maximum Possible Contrast Level for Silent Substitution: A Theoretical Model Applied to Melanopsin Stimulation. JOSA A. 2021; (9): 1312–1938
Reference
1. Ayoub T, Patel N. Age-related macular degeneration. J R Soc Med. 2009;102(2):56-61.
Reference
2. Vyawahare H, Shinde P. Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Cureus. 2022;14(9):e29583.
Reference
3. Gehrs K, A., et al. Age-related macular degeneration–emerging pathogenetic and therapeutic concepts. Ann Med. 2006;38(7):450-471.
Oculox's website contains product-related information restricted to healthcare
providers, as they pertain to medical devices for professional use only.
To meet the applicable regulations confirm your role.
Establish a comprehensive eye-healthcare platform from early diagnosis to effective treatment, ensuring global holistic care solutions.
Unlock Our
Expertise
and Services